Balyasny Asset Management LLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Balyasny Asset Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $3.31 Million - $5.93 Million	77,500 Added 38.75%	277,500 $12.8 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $5.13 Million - $6.97 Million	-70,000 Reduced 25.93%	200,000 $16.8 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $14.8 Million - $18.1 Million	270,000	270,000 $18 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.